echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > New drug research and development progress disclosed by Northeast Pharmaceutical

    New drug research and development progress disclosed by Northeast Pharmaceutical

    • Last Update: 2020-04-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Zhang Zhengwei, financial director of Northeast Pharmaceutical, stressed in the dingzeng roadshow that the company is now gradually completing the transformation from API to pharmaceutical industry chain, and the biopharmaceutical sector will also become a new performance growth point of the company

    "This year, it is expected that five biopharmaceuticals will be approved, and in the next three years, five to six hepatitis B and hepatitis C drugs will be approved."

    Wei Haijun, chairman of Northeast Pharmaceutical, also disclosed to investors that a new anti infective drug developed by the US Pharmaceutical Research Institute has completed in vitro test in Japan, "it is expected to be applied for clinical application in China within 4-5 years"

    After use, it will not produce drug resistance, which is subversive for the whole anti infective drug

    According to the State Food and drug administration, the only viable Bacillus licheniformis granules and capsules belonging to biological products of Northeast Pharmaceutical are in the "in review" stage, while the chemical eferene tablets and diclofenac sodium and lidocaine hydrochloride injection have just been applied for production, which is difficult to be approved within the year.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.